JMP Securities analyst Aaron Kimson maintained a Buy rating on Guidewire (GWRE – Research Report) today and set a price target of $250.00. See what stocks are receiving Strong Buy ratings from ...
In a report released today, Andrew Boone from JMP Securities maintained a Hold rating on Nerdy (NRDY – Research Report). The company’s shares closed last Friday at $1.52. See what stocks are ...
JMP Securities analyst Steven Delaney reiterated a Buy rating on Velocity Financial (VEL – Research Report) today and set a price target of $21.00. See what stocks are receiving Strong Buy ...
JMP Securities analyst Jordan Bender maintained a Buy rating on Full House Resorts (FLL – Research Report) today and set a price target of $5.00. See what stocks are receiving Strong Buy ratings ...
In a report released today, David Turkaly from JMP Securities reiterated a Hold rating ... Most recently, in November 2024, Dan Lemaitre, a Director at GMED sold 14,375.00 shares for a total ...
In a report released today, Patrick Walravens from JMP Securities maintained a Buy rating on Vertex (VERX – Research Report), with a price target of $61.00. The company’s shares closed ...
In a report released today, Nicholas Jones CFA from JMP Securities maintained a Buy rating on Grindr (GRND – Research Report), with a price target of $21.00. The company’s shares closed ...
JMP Securities analyst Mitchell Germain maintained a Buy rating on Plymouth Industrial Reit (PLYM – Research Report) today and set a price target of $24.00. The company’s shares closed ...
In a report released today, Nicholas Jones CFA from JMP Securities maintained a Buy rating on Offerpad Solutions (OPAD – Research Report), with a price target of $4.50. The company’s shares ...
In a report released today, Nicholas Jones CFA from JMP Securities maintained a Buy rating on CoStar Group (CSGP – Research Report), with a price target of $85.00. The company’s shares closed ...
JMP Securities analyst Jason Butler reiterated a Buy rating on Dynavax (DVAX – Research Report) today and set a price target of $33.00. The company’s shares closed yesterday at $13.33.
On Tuesday, JMP Securities maintained its Market Outperform rating for Astria Therapeutics (NASDAQ:ATXS) with a steady price target of $26.00, representing significant upside potential from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results